Bausch Health Companies | VRX - Capital Ordinário

Preço das Ações
7.69
Mudança Diária
0.10 1.32%
Mensal
9.54%
Anual
2.12%
Q2 Previsão
7.53




Capital Ordinário Alterar Data
Amgen USD 539M 1000K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bausch Health Companies USD 370.53M 59K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Danaher USD 707.7M 800K 2026-03
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Zoetis USD 424.93M 16.54M 2025-12